| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Camp4 Therapeutics Corp (CAMP) has 14 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. CAMP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.94M | $12.96M | - | |
| 10% | 2.94M | $12.96M | - | |
| 10% | 2.83M | $12.45M | - | |
| CEO | 425.0K | $1.87M | - | |
| 10% | 197.7K | $870.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | 5am Partners Vi, LLC | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +53.0% | -63.3% | -68.0% | |
| Oct 15, 2024 | Nashat Amir | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | New | -63.3% | -68.0% | |
| Oct 15, 2024 | Enavate Sciences Gp, LLC | 10% Owner | Buy | 1,363,636 | $11.00 | $14,999,996.00 | +56.3% | -63.3% | -68.0% | |
| Oct 15, 2024 | Ah Equity Partners Bio I, L.l.c. | 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +52.0% | -63.3% | -68.0% |